Genes and Diseases (Nov 2023)

A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma

  • Weidong Wang,
  • Wang Lv,
  • Hui Wang,
  • Yang Xu,
  • Junrong Yan,
  • Han-Ming Shen,
  • Liqun Shan,
  • Jian Hu

Journal volume & issue
Vol. 10, no. 6
pp. 2241 – 2244

Abstract

Read online

No abstracts available.